Bati Keagile, Kwape Tebogo Elvis, Chaturvedi Padmaja
Department of Biological Sciences, University of Botswana Private Bag UB0022, Gaborone, Botswana.
J Pharmacopuncture. 2017 Mar;20(1):45-51. doi: 10.3831/KPI.2017.20.008.
This study aimed to evaluate the hypoglycemic effects of an ethanol extract of (ECA) bark and the possible mechanisms of its action in diabetic albino rats.
ECA was prepared by soaking the powdered plant material in 70% ethanol. It was filtered and made solvent-free by evaporation on a rotary evaporator. Type 2 diabetes was induced in albino rats by injecting 35 mg/kg body weight (bw) of streptozotocin after having fed the rats a high-fat diet for 2 weeks. Diabetic rats were divided into ECA-150, ECA-300 and Metformin (MET)-180 groups, where the numbers are the doses in mg.kg.bw administered to the groups. Normal (NC) and diabetic (DC) controls were given distilled water. The animals had their fasting blood glucose levels and body weights determined every 7 days for 21 days. Oral glucose tolerance tests (OGTTs) were carried out in all animals at the beginning and the end of the experiment. Liver and kidney samples were harvested for glucose 6 phosphatase (G6Pase) and hexokinase activity analyses. Small intestines and diaphragms from normal rats were used for α-glucosidase and glucose uptake studies against the extract.
Two doses, 150 and 300 mg/kg bw, significantly reduced the fasting blood glucose levels in diabetic rats and helped them maintain normal body weights. The glucose level in DC rats significantly increased while their body weights decreased. The 150 mg/kg bw dose significantly increased hexokinase and decreased G6Pase activities in the liver and the kidneys. ECA inhibited -glucosidase activity and promoted glucose uptake in the rats' hemi-diaphragms.
This study revealed that ECA normalized blood glucose levels and body weights in type 2 diabetic rats. The normalization of the glucose levels may possibly be due to inhibition of -glucosidase, decreased G6Pase activity, increased hexokinase activity and improved glucose uptake by muscle tissues.
本研究旨在评估[植物名称]树皮乙醇提取物(ECA)对糖尿病白化大鼠的降血糖作用及其可能的作用机制。
将植物材料粉末用70%乙醇浸泡制备ECA。过滤后,通过旋转蒸发仪蒸发使其无溶剂。在给白化大鼠喂食高脂饮食2周后,注射35mg/kg体重的链脲佐菌素诱导2型糖尿病。糖尿病大鼠分为ECA - 150、ECA - 300和二甲双胍(MET)- 180组,数字为给予各组的剂量,单位为mg.kg.bw。正常(NC)和糖尿病(DC)对照组给予蒸馏水。在21天内,每7天测定动物的空腹血糖水平和体重。在实验开始和结束时对所有动物进行口服葡萄糖耐量试验(OGTT)。采集肝脏和肾脏样本进行葡萄糖6磷酸酶(G6Pase)和己糖激酶活性分析。使用正常大鼠的小肠和膈肌研究提取物对α - 葡萄糖苷酶和葡萄糖摄取的影响。
150和300mg/kg bw这两个剂量显著降低了糖尿病大鼠的空腹血糖水平,并帮助它们维持正常体重。DC大鼠的血糖水平显著升高,而体重下降。150mg/kg bw剂量显著增加了肝脏和肾脏中的己糖激酶活性并降低了G6Pase活性。ECA抑制了大鼠半膈肌中的α - 葡萄糖苷酶活性并促进了葡萄糖摄取。
本研究表明,ECA使2型糖尿病大鼠的血糖水平和体重恢复正常。血糖水平的恢复正常可能是由于抑制了α - 葡萄糖苷酶、降低了G6Pase活性、增加了己糖激酶活性以及改善了肌肉组织对葡萄糖的摄取。